(Q36802741)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17462077%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Viral vector vaccines make memory T cells against malaria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17462077%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

1 reference

Arturo Reyes-Sandoval

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17462077%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

John T. Harty

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17462077%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Stephen M Todryk

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17462077%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Stephen M Todryk

3

1 reference

16 August 2017

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17462077%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17462077%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17462077%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17462077%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

158-165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17462077%20AND%20SRC:MED&resulttype=core&format=json

Pre-erythrocytic malaria vaccines: towards greater efficacy

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Building better T-cell-inducing malaria vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Innate immune recognition of viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Vaccinia virus: a tool for research and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Dendritic cells infected with recombinant fowlpox virus vectors are potent and long-acting stimulators of transgene-specific class I restricted T lymphocyte activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Adenoviruses as vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

The maturation of murine dendritic cells induced by human adenovirus is mediated by the fiber knob domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

CD8+ T cell contraction is controlled by early inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Central memory and effector memory T cell subsets: function, generation, and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Programming, demarcating, and manipulating CD8+ T-cell memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Linear differentiation of cytotoxic effectors into memory T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Progressive differentiation and selection of the fittest in the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Committed to memory: lineage choices for activated T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Lineage relationship and protective immunity of memory CD8 T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Secondary memory CD8+ T cells are more protective but slower to acquire a central-memory phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Detailed analysis of intrahepatic CD8 T cells in the normal and hepatitis C-infected liver reveals differences in specific populations of memory cells with distinct homing phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2006.02552.X

Programmed contraction of CD8(+) T cells after infection.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265939

Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset

11 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265939

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

11 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265939

Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge

11 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265939

Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria

11 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265939

Dynamic programming of CD8+ T lymphocyte responses

11 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17462077

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17462077

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2567.2006.02552.X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17462077%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

PMC publication ID

2265939

0 references

1 reference